Multimodal Serum Profiling for Early Detection and Risk Assessment of Oral Potentially Malignant Disorders and Oral Cancer
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.5c06663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Panchali Saha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tata Memorial Centre, Advanced Centre for Treatment, Education and Research in Cancer, Kharghar, Navi Mumbai, Maharashtra 410210, India. Hauptthemen laut MEDLINE: Mouth Neoplasms, Early Detection of Cancer, Carcinoma, Squamous Cell, Oral Submucous Fibrosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) has high incidence rates in India, with poor survival rates due to late diagnosis. Oral potentially malignant disorders (OPMDs) such as leukoplakia (L) and oral submucous fibrosis (OSMF) present a critical window for intervention. Minimally invasive approaches capturing early biochemical alterations were investigated to improve early detection and stratification. Blood serum samples from 169 subjects, including healthy controls (C), tobacco habitués (TC), L, OSMF, and OSCC, were analyzed using Raman spectroscopy (RS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Principal component-based quadratic discriminant analysis (PC-QDA) models were built with RS data and validated on independent cohorts. Multivariate curve resolution-alternating least-squares (MCR-ALS) analysis identified altered spectral features. Global LC-MS/MS metabolite profiles were assessed by multivariate statistics and pathway enrichment. RS-based PC-QDA models achieved ∼95% accuracy in training and testing when C subjects were compared against TC, L, OSCC, and OSMF in a two-group model. A three-group model with C, TC, and oral diseases accurately classified >80% C and 86% oral disease subjects. The model stratifying L, OSMF, and OSCC identified 100% OSCC and 73-84% of L and OSMF in independent test sets. MCR-ALS revealed spectral features of albumin, immunoglobulins, carotenoids, and lipids, corresponding to LC-MS/MS findings of altered albumin-bound metabolites, bile acids, lipid metabolism, and oxidative stress. Serum RS demonstrated efficacy as a rapid, minimally invasive detection tool for oral disease stratification. LC-MS/MS identified metabolites and pathways aligning with RS spectral signatures. This multimodal approach shows promise for early detection and risk assessment of oral cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Tata Memorial Centre, Advanced Centre for Treatment, Education and Research in Cancer, Kharghar, Navi Mumbai, Maharashtra 410210, India.
- Training School Complex, Homi Bhabha National Institute, Anushakti Nagar, Mumbai, Maharashtra 400094, India.
- D Y Patil University School of Dentistry, Oral Medicine and Radiology, Navi Mumbai, Maharashtra 400614, India.
ORCID-Profile: Rukmini Govekar, C Murali Krishna
Zitieren
APA
Saha, P., Varyani, R., Hole, A., Joshi, P., Waghmare, M. S., Singh, A., Chaturvedi, P., Govekar, R., & Krishna, C. M. (2026). Multimodal Serum Profiling for Early Detection and Risk Assessment of Oral Potentially Malignant Disorders and Oral Cancer. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c06663
Vancouver
Saha P, Varyani R, Hole A, Joshi P, Waghmare MS, Singh A, et al. Multimodal Serum Profiling for Early Detection and Risk Assessment of Oral Potentially Malignant Disorders and Oral Cancer. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.5c06663
BibTeX
@article{Saha2026,
author = {Saha, Panchali and Varyani, Ronak and Hole, Arti and Joshi, Poonam and Waghmare, Mandavi S and Singh, Arjun and Chaturvedi, Pankaj and Govekar, Rukmini and Krishna, C Murali},
title = {Multimodal Serum Profiling for Early Detection and Risk Assessment of Oral Potentially Malignant Disorders and Oral Cancer},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.5c06663}
}
EUVIMED